4DMedical is trading at $3.34, down 5.11%, with no reliable company-specific catalyst identified for the September 8, 2026 decline.

  • The stock fell from the September 7, 2026 close of $3.52.
  • A routine issued-shares entry is listed for September 8, but available evidence does not establish it caused the drop.
  • Broader markets were essentially flat, offering little explanation.